Ambulatory IV infusion Pumps Global Market Report 2024

The ambulatory iv infusion pumps market size has grown steadily in recent years. It will grow from $0.81 billion in 2023 to $0.84 billion in 2024 at a compound annual growth rate (CAGR) of 3.3%. The growth observed in the historical period in the ambulatory IV infusion pumps market can be attributed to several key factors. These include the rapid growth in the elderly population, economic growth in emerging markets, and advancements in technology. These factors collectively contributed to the increased demand and adoption of ambulatory IV infusion pumps, reflecting the market's response to demographic trends, economic developments, and technological innovations during the historical period.

The ambulatory iv infusion pumps market size is expected to see steady growth in the next few years. It will grow to $0.97 billion in 2028 at a compound annual growth rate (CAGR) of 3.7%. Anticipated growth is driven by the increasing prevalence of chronic diseases, rising demand for improved infusion pumps, the impact of COVID-19, increased healthcare expenditure, and a growing number of oncology cases in the geriatric population. Key trends include a focus on smart ambulatory infusion pump devices and software, development of new products, deployment of advanced technologies, and considerations for acquiring smaller drug delivery device companies.

The escalating prevalence of chronic conditions such as chronic pain, cancer, and diabetes has become a significant driver for the ambulatory IV infusion pumps market. These pumps play a pivotal role in delivering pharmaceutical drugs vital for treating these diseases. With chronic illnesses witnessing a surge globally due to factors such as an aging population and shifts in societal behaviors, the demand for ambulatory IV infusion pumps - essential in administering chemotherapy drugs, pain relief medications, antibiotics, insulin, among others - has grown substantially. According to the World Health Organization's report in September 2023, chronic diseases account for approximately 74% of global deaths, totaling 41 million fatalities annually. This increasing prevalence underscores the market's anticipated growth in ambulatory IV infusion pumps.

The growth trajectory of the ambulatory IV infusion pumps market is further fueled by the increasing count of surgical procedures. These procedures involve medical interventions, often requiring controlled and precise administration of fluids, medications, and anesthetics, which the ambulatory IV infusion pumps provide. The pumps' ability to ensure accurate and continuous delivery of substances during surgeries significantly contributes to patient safety and the overall efficiency of surgical processes. For instance, data from the British Heart Foundation in January 2022 indicated nearly 284,000 individuals awaited critical heart-related operations and procedures in England by the end of November 2021. As these procedures continue to rise, the demand for ambulatory IV infusion pumps as a crucial tool in surgical settings is expected to grow in tandem.

Companies within the ambulatory IV infusion pump market are increasingly directing their efforts toward the development of smart infusion pumps. This shift aligns with the growing utilization of wireless technology in health monitoring devices, offering enhanced ease of use, connectivity, and data analysis capabilities. The integration of wireless functionality enables seamless data transfer from the device to smartphones or wireless devices using Bluetooth or cellular connections. This data is then processed for analysis, and the results are displayed, facilitating further study and assessment of an individual's health condition. Moreover, the introduction of software platforms designed for patient monitoring aims to minimize human error and streamline data-driven healthcare practices.

Major players in the ambulatory IV infusion pumps market are intensifying their focus on introducing safe infusion therapy solutions to optimize market revenue. These solutions encompass a comprehensive range of practices and protocols crafted to administer intravenous medications, fluids, and therapeutic agents with paramount emphasis on patient safety, reduced complication risks, and improved treatment outcomes. A notable example is Baxter International Inc.'s achievement in August 2022, gaining US Food and Drug Administration (FDA) clearance for the Novum IQ syringe infusion pump integrated with Dose IQ Safety Software. This innovative pump is engineered to deliver minute fluid volumes, including medications, parenteral nutrition, blood products, and enteral nutrition, at low flow rates. It seamlessly interfaces with hospital electronic medical records (EMRs) through Baxter's IQ Enterprise Connectivity Suite, ensuring compatibility with legally sanctioned administration sets, syringes, and medications for safe and effective usage.

In March 2022, Fresenius Kabi, a German pharmaceutical company, successfully acquired Ivenix for an upfront payment of $240 million, along with additional milestone payments. This strategic acquisition is aimed at accelerating innovation, expanding and enhancing the infusion therapy portfolio, and improving infusion capabilities for both companies. Ivenix, based in the United States, is recognized as a manufacturer of advanced infusion pumps, and its integration into Fresenius Kabi is expected to strengthen the capabilities and offerings in the field of infusion therapy.

Major companies operating in the ambulatory iv infusion pumps market report are Becton Dickinson and Company, Baxter International, B. Braun Holding GmbH & Co. KG, Smiths Medical, ICU Medical Inc., Fresenius Kabi, Terumo Corporation, Medtronic, IRadimed Corporation, Nipro Corporation, Sinomdt, Mindray, SCHILLER Healthcare India Pvt. Ltd., Johnson & Johnson, GE Healthcare, Covidien Healthcare India Private Limited, Fisher & Paykel Healthcare India Private Limited, Agappe Diagnostics Ltd., ARKRAY Healthcare Pvt. Ltd., Accord Medical Products Private Limited, Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co. Ltd., Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co. Ltd., Shanghai Runda Medical Technology Co. Ltd., Ambu Inc., Fresenius, Siemens, Stryker, Teleflex Medical, Beckman Coulter, St. Jude, Philips Healthcare, Draegerwerk AG, Masimo, 3M, Eitan Group, Q Core Medical, B. Braun Medical Inc.

North America was the largest region in the ambulatory IV infusion pumps market in 2023. Western Europe was the second largest region in the global ambulatory IV infusion pump market. The regions covered in the ambulatory iv infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ambulatory iv infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The ambulatory IV infusion pumps market, as covered in this report, is segmented by type into disposable infusion pumps and chemotherapy infusion pumps. Disposable infusion pumps are single-use devices utilized for the controlled delivery of medication into the patient's body. These pumps find applications in various medical fields such as chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other medical applications. These devices are employed by a range of end-users including hospitals, home healthcare, and others.

The ambulatory IV infusion pumps market research report is one of a series of new reports that provides ambulatory IV infusion pumps market statistics, including ambulatory IV infusion pumps industry global market size, regional shares, competitors with a ambulatory IV infusion pumps market share, detailed ambulatory IV infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory IV infusion pumps industry. This ambulatory IV infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ambulatory IV infusion pumps market consists of sales of disposable infusion pumps and chemotherapy infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.